| Presented by: | The American Society of Health-System Pharmacists |
| Lecturer | Stuart T. Haines, Pharm.D., BCPS, FCCP, FASHP, Paul P. Dobesh, Pharm.D., FCCP, BCPS (AQ Cardiology) and
William E. Dager, Pharm.D., FCSHP, FCCP |
| Approximate duration: | 2 hrs. |
| Summary points: | In this interactive, audiovisual activity, 3 experts in clinical pharmacy review the American College of Cardiology/American Heart Association guidelines on the use of anticoagulant and antiplatelet therapies for the management of patients with ST-segment elevation myocardial infarction (STEMI) and patients with unstable angina/non-ST-segment elevation myocardial infarction (NSTEMI). |
| Accreditation: | The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The program provides 2 hours (0.2 CEUs) of continuing education credit (program number 204-000-08-478-H01P). Expiration Date: February 28, 2010. |
| Other: | |
E-Mail this webcast/CME to a colleague
Cardiovascular Series: Guidelines for Anticoagulant and Antiplatelet Therapy in the Prevention and Treatment of Acute Coronary Syndrome: Incorporation into Clinical Practice
Go to webcast/CME
E-Mail this webcast/CME to a colleague
Remind me of this
